iValue Q1FY27: consol. PAT +52% YoY to ₹15.7 Cr, margins expand as net revenue falls 21%
PAT +51.74% YoY · revenue -21.14% · margins expanding
₹179.73 Cr
-21.14% YoY
₹15.72 Cr
+51.74% YoY
8.44%
+4pp YoY
₹2.9
iValue Infosolutions' consolidated (primary) Q1 FY27 (quarter ended June 30, 2026) PAT came in at ₹15.72 Cr, up 51.7% YoY from ₹10.36 Cr — a clean comparison since neither quarter carries exceptional items. Revenue from operations, by contrast, fell 21.1% YoY to ₹179.73 Cr from ₹227.90 Cr, even as gross billings to customers actually rose 5.7% YoY to ₹641.16 Cr (per the filing's own gross-to-net reconciliation in Note 6). The divergence is a business-mix effect — more revenue this quarter was booked on a net/agency basis (only the retained margin hits the P&L) versus gross/principal-basis deals — not a shrinking order book. Basic EPS was ₹2.90, up from ₹1.92 a year ago. Standalone confirms the same pattern isn't a subsidiary artifact: PAT ₹14.99 Cr (+47.4% YoY), revenue ₹151.62 Cr (-29.3% YoY).
Q1 FY-2027 vs prior quarters
Total expenses fell 25.2% YoY to ₹165.41 Cr, outpacing the revenue decline and driving the margin gain — the bulk of that came from purchases of stock-in-trade dropping 28.5% YoY to ₹128.78 Cr, consistent with the net-basis mix shift, while employee costs were roughly flat (+3.7% YoY to ₹19.70 Cr). That confirms the margin expansion is a revenue-mix effect rather than cost-cutting. Net profit margin (PAT/Total Income) rose to about 8.4% from 4.4% a year ago. Sequentially, though, both revenue (-34.1%) and PAT (-63.1%) fell sharply from the seasonally heavy March 2026 quarter (₹272.60 Cr revenue, ₹42.65 Cr PAT, ~15.3% NPM) — management has repeatedly flagged H2 as structurally stronger than H1, so this QoQ drop reads as seasonal rather than fresh deterioration.
The stock went into the print at ₹284.55, up 7.2% over the past month of trading.
Management is highly optimistic for FY27, expecting it to outperform FY26 in both revenue growth and profitability, driven by a strong pipeline, growing annuity revenues, accelerating AI and digital infrastructure opportunities, and operating leverage. They anticipate sustained growth of 18-20% on the top line and 20-2
— This quarter: beat
On the Q4 FY26 call, management guided FY27 revenue growth of 18-20% and PAT growth of 20-22%, with H2 expected to outperform H1. One quarter in, PAT growth (+51.7% YoY) is running well ahead of that annual pace, while net revenue (-21.1% YoY) is running behind the topline guide — though gross billings growth (+5.7% YoY), arguably the more relevant volume measure given the accounting mix shift, is closer to (if still short of) the guided range. No Q1-specific street estimates could be located; the closest available analyst reference (Simply Wall St) pegs full-year FY27 EPS growth at ~34% to ₹24.10 on an annualised basis — this quarter's ₹2.90 EPS is only one quarter into that bar, so it's too early to score a beat or miss against it. Alongside the results, the company disclosed CEO Shrikanth Manohar Shitole's resignation (letter dated July 15, 2026, effective July 31, 2026, for personal reasons) and allotted 1,23,280 ESOP shares, lifting paid-up capital marginally to ₹10.95 Cr. The filing carries no separate management commentary or press release beyond the regulatory notes.
W1
CEO succession — Shrikanth Shitole's exit is effective July 31, 2026; watch for a successor announcement, potentially around the Aug 19, 2026 AGM
W2
Net revenue-from-operations recovery toward FY27's guided 18-20% topline growth — Q1's ₹179.73 Cr (-21.1% YoY) needs a strong H2, consistent with management's own 'H2 stronger than H1' framing
W3
Durability of the NPM expansion (~8.4% this quarter vs ~4.4% a year ago) as the net-vs-gross billing mix continues to evolve through FY27
Clean, high-res PDF (no scan artifacts); both statements unaudited/limited-reviewed by PwC. No exceptional items in Q1FY27 or Q1FY26, so YoY PAT comparison is clean (Q4FY26 had a small ₹50L/₹70L exceptional reversal, irrelevant here). Revenue from operations fell YoY despite gross billings to customers rising, due to a net-vs-gross (agency vs principal) revenue-recognition mix shift disclosed in Note 6/5 of the filing — easy to misread in isolation. CEO resignation and ESOP allotment disclosed in the same filing.
Margins recovered, but sales tumbled—and guidance looks implausible
PAT jumped 52% and margins expanded, but revenue plummeted 21% year-over-year and 34% sequentially. This directly contradicts management's claim of strong demand and casts serious doubt on the company's 20% full-year growth target.
₹15.7 Cr
+51.7% YoY (vs ₹10.4 Cr prior)
₹179.7 Cr
-21.1% YoY, -34.1% QoQ
8.1%
+130 bps YoY; pricing discipline holds
The revenue contradiction
Management opened the call asserting strong demand, positive order trends, and confidence in full-year guidance. But the numbers tell a different story: revenue fell 21% year-over-year to ₹179.7 Cr and 34% quarter-over-quarter. This is not softness in one segment—it is a breadth collapse. Cybersecurity, the company's core engine (44% of sales), grew only 8%, falling far short of peer growth rates (25–30%). ALM imploded, down roughly 60%, blamed on customer budget reallocation to data center infrastructure. DCI did surge 180%, but from a small base; the absolute contribution was insufficient to offset the bleed elsewhere. The net result: a company that shipped fewer rupees of revenue this quarter than in any of the three prior quarters, yet claimed momentum.
Why the profit beat—and why it is not what it looks like
PAT grew 52% to ₹15.7 Cr, which on first glance suggests operational resilience. But the Q1 FY26 comparison point (₹10.4 Cr) was depressed by forex headwinds and low-margin deals. The real story is margin recovery: gross margin expanded 130 basis points to 8.1% (from 6.8% prior), driven by forex tailwinds, avoidance of low-margin business, and pricing discipline. This margin discipline is genuine and credible. But it was achieved on a 21% smaller revenue base—a poor trade-off for growth investors. Operating EBITDA rose 28% to ₹20.2 Cr, but this is a story of doing more with less, not of underlying volume or demand strength.
Management's claims vs. what holds up
Strong demand, positive order trends, full-year guidance on track
ContradictedRevenue -21% YoY, -34% QoQ; contradicts narrative
PAT grew 52% to ~₹16 Cr
Supported₹15.7 Cr, +51.7% YoY—matches; but on soft prior-year base
Gross margin recovered to 8.1% vs 6.8% prior
Supported8.1% confirmed; achieved despite same INR depreciation headwind
DCI grew 180% YoY; AI tailwind evident
PartialGrowth real; ~22% of sales (~₹141 Cr); but from low base; budget reallocation vs. net-new unclear
Will achieve 20% FY27 growth in gross sales and PAT
OverstatedQ1 -21% revenue requires 35–40% H2 growth; implausible without major sequential rebound
Annuity business at 46%, growing 14% YoY
SupportedAnnuity 46.4% of sales, +13.7% YoY—matches; supports recurring revenue trajectory
What changed on this call
CEO departure mid-IPO cycle; Sunil Pillai and Krishna Raj Sharma now co-lead. External CRO/CBO/CTO hires backfill, but team is unproven.
Segment mix deteriorated: DCI +180% masks Cybersecurity +8% (below peers) and ALM ~−60%. Strategy shifting to AI/infrastructure, away from core security.
Pipeline reaffirmed at ₹6,150 Cr (+6% QoQ), but conversion assumptions (30–35%) untested in current downturn.
Gross sales metric (₹641 Cr) vs. reported revenue (₹179.7 Cr) mismatch unresolved. Likely billings vs. revenue or timing gap; requires clarification.
The bull-bear ledger
AI/DCI structural tailwind is real; 180% growth and Arista partnership position iValue well for data center capex wave.
Annuity base now 46% of sales and growing; recurring revenue de-risks full-year visibility.
Margin discipline proven: 8.1% gross margin despite INR headwinds; pricing power demonstrated.
Revenue collapsed 21% YoY, 34% QoQ—contradicts guidance narrative and suggests demand weakness, not just cycle.
20% FY27 guidance requires 35–40% H2 growth after -21% Q1; credibility is now the critical factor.
CEO departure + interim co-leadership introduces governance and execution risk during turnaround cycle.
Cybersecurity growth (8%) lags peers (25–30%); no clarity on whether market share, pricing, or product issue.
Risks, ranked by how much they should concern a holder
Guidance execution—20% FY27 target at risk
HighQ1 revenue -21% YoY means remaining three quarters need ~35–40% sequential growth to hit target. Implausible without a step-change in demand. If guidance misses, stock reprices sharply downward.
Segment concentration and health deteriorating
HighCybersecurity (44% of sales) growing only 8% vs peers 25–30%; no compelling reason provided. If structural (share loss, pricing power), it undermines the core. DCI surge is real but from small base; ALM collapse is cyclical but depth unknown.
Leadership vacuum mid-cycle
MediumCEO departed post-IPO; Sunil + KRS co-lead, aided by new external CRO/CBO/CTO hires. Team unproven during 20% growth target ramp. Execution missteps cost credibility.
Demand headwinds persist
MediumCustomer budget freezes and supply chain delays (iValue 1.5 months vs some OEMs 7–8 months) noted. Pipeline conversion (30–35%) assumes normal demand; downturn could compress to 20–25%, requiring deal deferral.
Revenue metric mismatch (gross sales vs. reported revenue)
MediumManagement cited ₹641 Cr gross sales; filed revenue ₹179.7 Cr (3.6× gap). No reconciliation provided. Could signal billing/recognition timing risk or metric confusion.
How the street is positioned
The market's verdict on the quarter is clear: stock fell 3.78% on day 1 post-announcement (Jul 29) and remained down 3.46% by day 3, with no follow-through buying. This is not a dip-buy moment; it is a downgrade in motion. Price currently sits at ₹276.5, down 18.68% from its all-time high of ₹340, but still 33.15% above its 52-week low of ₹207.66. Technically, the RSI is at 19.6 (oversold), yet institutional buyers have not stepped in aggressively. Ownership tells the story: FII holdings fell 137 basis points to 2.22% (from 3.59% a quarter ago), while DII rose 206 basis points to 15.25%. Promoter holding remains flat at 32.08%. Bulk deal activity shows institutional buyers accumulating in the ₹260–₹262 band (360 ONE PIPE FUND ~19.2M shares, others), but one large seller (SUNDARA MAURITIUS ~5.7M shares at ₹260.20) hints at rotation out of longer-term holders. The stock is being repriced lower, with DII step-buying into weakness but FII exiting. This is consistent with a shift from growth story to uncertainty story.
The debate
1 · Q2 FY27 earnings (Oct–Nov 2026)
The make-or-break quarter. Revenue needs to show 10%+ sequential growth to suggest the year is salvageable. Look for: (a) Budget normalization into DCI/AI (confirmed net-new vs. reallocation), (b) ALM recovery narrative, (c) Cybersecurity stabilization or explanation of the 8% lag, (d) Pipeline conversion rate (was it 30–35% in Q1, or lower due to budget freeze?). If Q2 revenue is still -5% to +5% YoY, 20% FY27 is mathematically impossible.
2 · Supply chain normalization and capex cycle visibility
iValue cited 1.5-month supply delays (vs 7–8 months for some OEMs). If this normalizes in Q2, deal velocity should improve. Arista pipeline and private data center (captive DC) deal flow are key; large-ticket closures (₹150+ Cr billings) would signal H2 capex wave is real.
3 · External CEO search and interim leadership credibility
If a permanent external CEO is announced, it signals the board is confident in the turnaround thesis. Sunil + KRS must prove execution on pipeline conversion and gross margin defense until then. Any margin slippage or pipeline revision downgrades credibility further.
4 · Gross sales vs. revenue reconciliation
Clarify the ₹641 Cr gross sales vs ₹179.7 Cr reported revenue gap. If it is billings/TCV timing, quantify the forward impact on recognized revenue. If it is a different metric, explain what it measures and why it matters. Unresolved, this sows doubt.
Ivalue is holding its margin discipline, and the AI/DCI thesis has structural merit. But Q1 broke the revenue story—a 21% drop contradicts the 'strong demand' narrative and makes the 20% FY27 guidance implausible without a 35–40% H2 rebound. The CEO exit mid-IPO and interim co-leadership add near-term execution risk.
The stock is fairly valued on downside now, with FII exiting and DII rotating in at ₹260–₹262. RSI 19.6 signals oversold conditions, but no follow-through buying suggests the market is waiting for Q2 credibility.
For holders: hold for Q2 credibility. For prospective buyers: wait for evidence of sequential revenue growth (10%+ QoQ) or explicit guidance revision. The number to track from here is Q2 revenue; if it is still negative or flat YoY, the 20% target is gone and the stock reprices to reflect a 10–12% growth compounder, not a 20% growth story.
Growth stalled, guidance at risk despite AI tailwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Q1 FY26 was an outlier (low margins, forex headwinds); management's current 'positive demand' tone contrasts sharply with -21% YoY revenue and -34% QoQ decline, raising guidance credibility concerns.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong PAT growth (+52%) and margin recovery, but revenue collapsed -21% YoY, undercutting 20% FY27 guidance. AI-led DCI surge (+180%) is structurally bullish long-term; however, Q1's sequential -34% revenue decline, cybersecurity stalling at 8%, and mid-IPO CEO departure signal near-term execution risk. Maintain hold pending Q2 visibility.
₹179.7 Cr
Revenue · −21.1% YoY₹15.7 Cr
Reported PAT · +51.7% YoYExpanding
Margins · vs guidance: OverstatedDid the claims hold up?
PAT grew 52% YoY to ~₹16 Cr
METPAT ₹15.7 Cr, +51.7% YoY — matches claim; Q1 FY26 was soft (₹10.4 Cr) due to forex headwinds
Gross sales grew 5.7% YoY to ₹641.2 Cr
UnverifiedReported revenue ₹179.7 Cr; gross sales figure (₹641 Cr) ≠ filed revenue — likely billings or different metric; reconciliation unclear
Strong demand, positive order trends, FY27 in line with expectations
MISSRevenue YoY -21.1%, QoQ -34.1% — contradicts 'strong demand' narrative; Q1 was softer than prior quarters despite claimed momentum
Cybersecurity grew 8%, remains 44% of revenue; DCI grew 180%
PartialOverall revenue negative; cybersecurity 8% growth implies other segments (ALM, hardware) declined sharply; DCI growth from small base
Annuity recurring business growing 14% YoY at 46% of sales
METAnnuity at 46.4% vs 43.1% prior year (up 3.1 points); standalone growth ~13.7% claimed, supported by improving working capital and cash flow
Margin recovery: gross margin 8.1% vs 6.8% prior year
METNPM 8.4%, OPM 9.7% reported; gross margin % improvement matches; achieved despite same INR depreciation headwind as Q1 FY26
Will achieve 20% FY27 growth in gross sales and PAT
OVERSTATEDQ1 revenue -21% YoY; would require 35-40% growth in remaining 3 quarters to hit 20% full-year target — implausible without major sequential rebound
Earnings quality
What changed since the last call
Revenue trajectory deteriorated
DowngradeQ1 FY27 -21% YoY vs. prior Q4 +12% YoY; sequential -34% decline signals deceleration from '19.5% FY26 growth target. Guidance 20% at risk.
Guidance formally reaffirmed but implicitly weakened
NeutralManagement restated 20% FY27 growth target (matched prior call); no explicit cut. But negative Q1 + seasonal H2 upside now required to hit target—credibility stressed.
Margin mix improved; ILM pressure absorbed
UpgradeGross margin 8.1% (vs 6.8% prior, up 130 bps) despite INR depreciation; shows pricing discipline. Forex tailwind worked, low-margin deals avoided.
Leadership structure changed mid-IPO cycle
DowngradeCEO stepped down July 2026 (post-IPO ~late June). Sunil + KRS joint takeover introduces governance risk. External CRO/CBO hires backfill but new team unproven.
AI/DCI demand thesis validated; execution timing risky
NeutralDCI +180%, Arista partnership bullish, supply chain easing noted. However, Q1 saw budget reallocation (not net-new); upside conditional on capex acceleration in H2.
The Q&A
Analysts pressed on cybersecurity underperformance (8% vs peers 25-30%), ALM collapse (-60%), hardware deflation impact, and net-new sales risk with 46% annuity base. Management held to guidance but offered few specifics; blamed budget reallocation, not demand absence. Q&A tone shifted from optimistic to defensive mid-call.
Cybersecurity growth lag — Hitesh Goel, Aurigin Capital
PartialBudget reallocation to DCI temporary. Cybersecurity remains 44% of mix, 45-50% long-term target. Norm will return Q3 onwards.
Revenue softness reconciliation — Vibhav Khandelwal, Laburnum Capital
PartialFY26 was 10-year CAGR 23% revenue, 28% PAT. Business lumpy; H2 cycles strong. Q1 exceptional deals happened Q1-Q2 last year, not Q3-Q4.
Data center TAM and share opportunity — Balaji Subramanian, IIFL
AnsweredInfrastructure buildout phase has limited upside. Real opportunity when capacities online. Private data centers (captive) sweet spot, not public hyperscaler deals.
CEO departure rationale — Shlok Akolia, Xylem Investments
AnsweredNo restructuring. CEO (Shrikant) was interim post-IPO; Sunil stepped back to focus on investor exits and overseas. KRS took international role. Team strengthened with CBO/CRO/CTO hires.
OEM consolidation risk — Vibhav Khandelwal, Laburnum Capital
PartialConsolidation ongoing 2-4 years. Our OEMs acquire peers (we win new products), and our OEMs acquired (we onboard acquirer's platform). No revenue loss seen to date.
Annuity revenue allocation with SIs — Gokul, BTH Capital
AnsweredWe propose TCV (3-9 yr) to SI; first year ~60% (ACV), rest split annuity. SI incentivized to return to us. Not contractual but depends on our value add and support.
Hardware deflation impact on volumes — Bhavin Shah, Latent Advisors
PartialPrices up selectively; customers freeze budgets, push for discounts. Volume flat YoY; no degrowth. Margin pressure managed via software mix.
Deal pipeline stages and conversion timeline — Meet Mehta, Prasun Exponentials
PartialQuote to order <1 month. Early funnel to quote stage varies. TCV deal: ~60% ACV year 1, 10% per annum annuity. Depends on deal type and stage in funnel.
Guidance
FY27 gross sales +20% YoY
MediumReaffirmed from prior call. Q1 -21% revenue creates 35-40% H2 growth requirement. Seasonal strength (H2 > H1) cited; but execution risk elevated.
OPM/NPM: ~10% on yearly basis (historical range)
MediumQ1 delivered OPM 9.7%, NPM 8.4%. Guidance cites annuity scaling and margin discipline. Appraisal cycle cost headwind from Q2 (July onwards) could offset gross margin gains.
No incremental capex vs prior years; COE investments in line with historical
HighManagement stated no significant incremental capex for FY27. Suggests asset-light model continues; growth via OEM partnerships, not infrastructure build.
Risks the call surfaced
Guidance execution
HighWith negative Q1 and seasonal H2 strength unproven, reaching 20% full-year growth appears unattainable. Management faces credibility loss if guidance missed.
Segment concentration
MediumCybersecurity (44%) growing only 8%, below target; DCI surged 180% from small base; ALM crashed ~60%. Mix volatility and segment health uneven; cybersecurity underperformance vs peers (25-30% growth) signals potential share loss or market saturation.
Leadership & governance
MediumCEO (Shrikant, interim post-IPO) stepped down July 2026 for personal reasons. Sunil Pillai and Krishna Raj Sharma co-lead; Sunil on India ops, KRS on international. Backfilled with external CRO/CBO/CTO hires. Execution risk elevated during turnaround and overseas expansion.
Demand side execution
MediumSupply chain impact ongoing ~1 year; now 'cyclical'. Customers freeze budgets, push for discounts. While hardware prices inflated 40%, iValue cites volume flat YoY; margin pressure offset by mix. But volume flatness at -21% revenue suggests pricing/mix headwind real.
Revenue recognition complexity
MediumiValue proposes TCV (3-9 years) to end customers via System Integrators. First-year ACV ~60%, annuity 10% per annum. Annuity 46.4% of sales creates revenue timing risk if deal stages shift. SI channel (>70% inferred) means SI decisions control annuity renewals (non-contractual).
Management
Score 6/10. Clear on structure, honest on challenges (ALM reallocation, supply delays, budget freezes acknowledged). Less candid on why cybersecurity underperforms peers or why gross sales (₹641 Cr) vs reported revenue (₹179.7 Cr) differ. Delivered 19.5-20% FY26 growth as guided; Q1 FY27 -21% miss signals near-term headwind. 10-year CAGR 23-28% credible but requires annual data to verify.
1 · Q2 FY27 (Aug-Sep 2026)
Budget reallocation into DCI/AI infrastructure; supply chain easing; ALM normalization expected
2 · Q3 FY27 (Oct-Dec 2026)
Year-end enterprise budget cycles; seasonally strongest for iValue (H2 >> H1); large deal closures expected
3 · FY27 full-year (Mar 2027)
Interim management team (Sunil/KRS) must prove 20% guidance achievable; next external hire for permanent CEO could signal stability
Maintain hold pending Q2 visibility.